Antiviral activity and protection of cells against human immunodeficiency virus type-1 using an antisense oligodeoxyribonucleotide phosphorothioate complementary to the 5′-LTR region of the viral genome
- 12 December 1995
- Vol. 166 (2) , 227-232
- https://doi.org/10.1016/0378-1119(95)00582-x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Biochemical and Genetic Definition of the Cellular Protease Required for HIV-1 gp160 ProcessingPublished by Elsevier ,1995
- Comparison of deoxyoligonucleotide and tRNA(Lys-3) as primers in an endogenous human immunodeficiency virus-1 in vitro reverse transcription/template-switching reaction.Published by Elsevier ,1994
- GEM* 91—An Antisense Oligonucleotide Phosphorothioate as a Therapeutic Agent for AIDSAntisense Research and Development, 1992
- Antisense Oligodeoxyribonucleotides Inhibit the Expression of the Gene for Hepatitis B Virus Surface AntigenJournal of General Virology, 1990
- Inhibition of herpes simplex virus type 2 growth by phosphorothioate oligodeoxynucleotidesAntimicrobial Agents and Chemotherapy, 1990
- Designing antisense oligonucleotides aspharmaceutical agentsTrends in Pharmacological Sciences, 1989
- Synthesis of phosphorothioate analogues of oligodeoxyribonucleotides and their antiviral activity against human immunodeficiency virus (HIV)Gene, 1988
- Trans -Activator Gene of Human T-Lymphotropic Virus Type III (HTLV-III)Science, 1985
- NUCLEOSIDE PHOSPHOROTHIOATESAnnual Review of Biochemistry, 1985
- Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirusNature, 1985